2020

16/12/2020

Proteomics International interviewed for Australian Government R&D Tax Incentive podcast

26/11/2020

AGM Presentation 2020

12/11/2020

Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx

12/11/2020

Proteomics inks kidney disease test deal in Mid-East – The West Australian

12/11/2020

Middle East is next market for PromarkerD immunoassay test

05/11/2020

PromarkerD clinical assay performance results published

05/11/2020

Clinical assay performance validates Proteomics kidney test – The West Australian

05/11/2020

Proteomics: ‘Studies Back PromarkerD For Kidney Disease’ – Biotech Daily

04/11/2020

$1.1m tax rebate booster for Proteomics coffers – The West Australian

03/11/2020

Proteomics International Laboratories (ASX:PIQ) receives $1.1M R&D tax refund – The Market Herald

02/11/2020

Rapid oesophageal cancer test – 9 News (Television)

31/10/2020

October Newsletter 2020

28/10/2020

Proteomics’ $6m cap-raising lures UK institutions – The West Australian

24/10/2020

Proteomics International (ASX:PIQ) to raise $6M for high-tech blood test – The Market Herald

23/10/2020

Proteomics International raises $6m in heavily oversubscribed Placement

20/10/2020

Proteomics signs deal for distribution of PromarkerD in Italy – Biotech Dispatch

16/10/2020

Proteomics strikes kidney disease test deal in Italy – The West Australian

16/10/2020

Proteomics International Inks Italian Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx

16/10/2020

Proteomics International Laboratories (ASX:PIQ) signs distribution deal for diabetic kidney disease – The Market Herald

16/10/2020

First distribution agreement for PromarkerD immunoassay

16/10/2020

PromarkerD showcased at ASN Kidney Week 2020 Reimagined

12/10/2020

The West Australian – Major clinical study validates Proteomics kidney test

12/10/2020

The Market Herald – Proteomics (ASX:PIQ) partners up with QIMR Berghofer Institute

12/10/2020

PromarkerD international validation study results published

09/10/2020

Partnership with QIMR Berghofer targets oesophageal cancer

09/10/2020

The West Australian – Proteomics JV developing blood test for oesophageal cancer

23/09/2020

Small Caps – Tony Locantro: what’s happening in the gold sector and 6 biotech stocks

06/09/2020

Proteomics International at Perth Protein Group Inaugural AGM

26/08/2020

Investor Presentation – August 2020

18/08/2020

BioWorld – Proteomics rolls out blood-based diagnostic to predict diabetic kidney disease

31/07/2020

July Newsletter 2020

30/07/2020

6PR (Audio) – How’s this! – a blood test that can predict you have diabetic kidney disease 4 years before you get it!

28/07/2020

The West Australian – Proteomics builds global patent protection for kidney test

27/07/2020

PromarkerD Intellectual Property portfolio expands

17/07/2020

Dr Amy Mottl on PromarkerD Watch →

19/06/2020

360Dx – Proteomics International Presents Study Data Supporting PromarkerD Kidney Disease Test

17/06/2020

Dr Michael Shanik on PromarkerD Watch →

15/06/2020

Investor Insight – Proteomics International’s predictive test for diabetic kidney disease successfully validated in major clinical study

15/06/2020

The Market Herald – Proteomics (ASX:PIQ) validates prognostic diabetes kidney test

15/06/2020

Business News – Proteomics achieves clinical validation for kidney test

15/06/2020

The West Australian – Proteomics achieves clinical validation for kidney test

15/06/2020

Big pharma clinical study validates PromarkerD kidney test

15/06/2020

International Study Validates PromarkerD Predictive Test for Diabetic Kidney Disease – Investor Teleconference Listen →

14/06/2020

Sunday Times – Kidney test win

11/06/2020

Presented PromarkerD clinical validation results with US Big Pharma

10/06/2020

Professor Tim Davis on PromarkerD Watch →

09/06/2020

PIQ Investor Presentation – 9th June 2020

27/05/2020

Business News – Proteomics to develop ‘rapid-test’ for COVID-19

26/05/2020

The West Australian – Proteomics to develop ‘rapid-test’ for COVID-19

26/05/2020

The Market Herald – Proteomics International (ASX:PIQ) receives COVID-19 research grants

25/05/2020

Proteomics International receives COVID-19 research grants

30/04/2020

April Newsletter 2020

20/04/2020

360Dx – Proteomics International Nabs CE Mark for Kidney Disease Immunoassay Kit

16/04/2020

Finfeed – Proteomics awarded vital CE Mark registration for PromarkerD

16/04/2020

The Market Herald – Proteomic (ASX:PIQ) gets CE Mark for PromarkerD Immunoassay Kit

16/04/2020

CE Mark for PromarkerD Immunoassay Kit

07/04/2020

Diagnostics R&D expanded: the Promarker™ Pipeline

31/03/2020

Proteomics International expands study with US big pharma

23/03/2020

Proteomics International to patent biomarkers for diagnosis of endometriosis

23/03/2020

WA company takes further step towards blood test for endometriosis

06/03/2020

The West Australian – Biotech on the global map

26/02/2020

The Naked Scientists – Predicting diabetic kidney disease

10/02/2020

PromarkerD presented at Australasian Proteomics conference

31/01/2020

January Newsletter 2020

14/01/2020

CE Mark for PromarkerD Hub predictive software for DKD